Skip to content
Screener

Tectonic Therapeutics TECX Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Septerna, Inc. logo
Septerna, Inc.SEPN
$1.23M+310%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$7.34M+37.6%
Regenxbio logo
RegenxbioRGNX
$5.9M+214%
ALN
Alnylam PharmaceuticalsALNY
Opko Health logo
Opko HealthOPK
Celcuity logo
CelcuityCELC

Other financials

Income statement

See full
Operating income-$27.3M-49.2%
Net income-$25.2M-58.7%
EPS (diluted)-$1.34-44.1%

Balance sheet

See full
Cash & equivalents$236.9M-22.8%
Total debt$4.9M+86.1%
Total equity$230.4M-23.5%
Total assets$246.6M-21.7%

Cash flow

See full
Operating cash flow-$18.4M-40.7%
CapEx$19.0K-29.6%
Free cash flow-$18.4M-40.6%

Valuation

See full
Market cap$639.46M+54.6%
Enterprise value$407.46M+219%

Returns & leverage

See full
Return on equity-31.4%
Debt / equity0.0×
Current ratio18.5×-4.4×

Where this comes from

Reported directly by Tectonic Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Tectonic Therapeutics’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:19 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-212016
Line itemMarch 31, 2026December 31, 2025
Finance right-of-use assets, net410495
Operating right-of-use assets4,108874
Restricted cash485485
Other assets663640
Total assets$246,577$261,038
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable$2,554$1,093

Item 1. Financial Statements.

FAQ

What is Tectonic Therapeutics's deferred tax assets and other non-current assets?
Tectonic Therapeutics (TECX) reported deferred tax assets and other non-current assets of $663K in Q1 2026.
How has Tectonic Therapeutics's deferred tax assets and other non-current assets changed year-over-year?
Tectonic Therapeutics's deferred tax assets and other non-current assets increased by 380.4% year-over-year, from $138K to $663K.
What is the long-term trend for Tectonic Therapeutics's deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Tectonic Therapeutics's deferred tax assets and other non-current assets has grown at a 8.0% compound annual growth rate (CAGR), from $436K to $640K.

Ask your AI about Tectonic Therapeutics's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude